CHOC is at the forefront to offer breakthrough enzyme replacement therapy to improve the quality of life for children with CLN2.
Virtual psychosocial support improves adolescent and young adult oncology outcomes during pandemic
When the pandemic hit, CHOC’s psychosocial programs for adolescents and young adults with cancer went virtual but brought new opportunities.
Quality improvement effort reduces chronic lung disease in preterm infants
After years of research, CHOC implemented advanced protocols that could produce a distinct reduction in chronic lung disease in infants.
CHOC’s After Cancer Treatment Survivorship program recognized with an award for collaboration
The ACTS program at the Hyundai Cancer Institute at CHOC receives recognition for their work to provide long-term care to cancer survivors.
Treating neonatal arteriovenous malformation with neurointerventional surgery
CHOC takes a multidisciplinary approach to detect AMV and treat it with life-saving neurointerventional surgery.
Precision 3D neuroimaging better pinpoints epileptogenic foci
CHOC is at the forefront of bringing precise, advanced 3D brain imaging to neurologists and their patients.
